ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,601
Diagnostic referrals
1,060
Outstanding pathways
335

Screening pathway

  1. Screening5,601Encounters
  2. Positive finding1,983Documented findings
  3. Referral1,060Diagnostic referrals
  4. Follow-up1,284Diagnostic visits
  5. Outcome725Resolved pathways

Stage totals use different units. Pending pathways: 285. Insufficient observation: 50.

Participant insight

Expanded synthetic participant 0800 · EXP-0800Synthetic · Site E

Full participant history through 2027-10-08, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2026-12-22
  4. · Screening · HPV DNA · Repeat · Prior HPV positive
  5. · Screening result · HPV DNA · HPV detected · Adequate
  6. · Diagnostic referral · EXP-0800-T-R
  7. · Contact attempt · Reached
  8. · Diagnostic booking · Initial booking
  9. · Barrier documented · Transport difficulty
  10. · Navigation intervention · Coordination support
  11. · Diagnostic visit · Missed
  12. · Diagnostic booking · Rebooking
  13. · Diagnostic visit · Attended
  14. · Diagnosis · Colposcopy · Biopsy collected
  15. · Diagnosis · Histopathology · High-grade lesion
  16. · Follow-up disposition · Resolved · EXP-0800-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0770 · Expanded synthetic participant 0770Site C — Rural Outreach Programme
EXP-0772 · Expanded synthetic participant 0772Site A — Urban Referral Hub
EXP-0773 · Expanded synthetic participant 0773Site C — Rural Outreach Programme
EXP-0774 · Expanded synthetic participant 0774Site D — Community Engagement Programme
EXP-0775 · Expanded synthetic participant 0775Site A — Urban Referral Hub
EXP-0776 · Expanded synthetic participant 0776Site B — Peri-Urban Access Programme
EXP-0777 · Expanded synthetic participant 0777Site E — Resource-Constrained Navigation Programme
EXP-0778 · Expanded synthetic participant 0778Site E — Resource-Constrained Navigation Programme
EXP-0779 · Expanded synthetic participant 0779Site E — Resource-Constrained Navigation Programme
EXP-0780 · Expanded synthetic participant 0780Site D — Community Engagement Programme
EXP-0781 · Expanded synthetic participant 0781Site B — Peri-Urban Access Programme
EXP-0782 · Expanded synthetic participant 0782Site D — Community Engagement Programme
EXP-0783 · Expanded synthetic participant 0783Site E — Resource-Constrained Navigation Programme
EXP-0784 · Expanded synthetic participant 0784Site A — Urban Referral Hub
EXP-0785 · Expanded synthetic participant 0785Site E — Resource-Constrained Navigation Programme
EXP-0787 · Expanded synthetic participant 0787Site D — Community Engagement Programme
EXP-0788 · Expanded synthetic participant 0788Site D — Community Engagement Programme
EXP-0789 · Expanded synthetic participant 0789Site E — Resource-Constrained Navigation Programme
EXP-0790 · Expanded synthetic participant 0790Site E — Resource-Constrained Navigation Programme
EXP-0791 · Expanded synthetic participant 0791Site E — Resource-Constrained Navigation Programme
EXP-0792 · Expanded synthetic participant 0792Site A — Urban Referral Hub
EXP-0793 · Expanded synthetic participant 0793Site C — Rural Outreach Programme
EXP-0794 · Expanded synthetic participant 0794Site B — Peri-Urban Access Programme
EXP-0795 · Expanded synthetic participant 0795Site D — Community Engagement Programme
EXP-0796 · Expanded synthetic participant 0796Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1970
HPV DNA
2904
Cytology
727

Navigation activity

Barrier documented
937
Contact attempt
1505
Navigation intervention
417
Diagnostic booking
1301
Diagnostic visit
1284

Documented barriers

Contact difficulty
298
Transport difficulty
311
Appointment coordination
328

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.